Since the FDA announced that tirzepatide is (for now) out of shortage, APC’s Scott Brunner has been...
Media turned to APC over Hims & Hers Super Bowl ad
In the run-up to the Super Bowl, APC spent considerable time correcting misinformation about whether that Hims & Hers ad violated laws or regulations. (Short answer: It didn’t, but it did push the envelope. See APC’s statement on the Hims & Hers Ad.)
Here’s just a partial list of where APC was quoted in the run-up to the Stomping of the Chiefs:
-
CNBC: Hims & Hers faces scrutiny from senators on Super Bowl ad that ‘risks misleading’ patients
-
Bloomberg: Super Bowl Ad Selling Weight Drug Shows Wild West of Copycats
-
San Francisco Chronicle: Two U.S. senators slammed an S.F. telehealth company’s Super Bowl ad. Here’s why
-
2 Urban Girls: Alliance for Pharmacy Compounding responds to Hims & Hers Super Bowl Ad (with pick-up in MSN)
-
Managed Healthcare Executive: Hims and Hers Superbowl Ad Draws Controversy Over Safety
-
Inside Health Policy: Hims & Hers GLP-1 Super Bowl Ad Sparks Debate On FDA Compliance
-
Medical Marketing & Media: Hims’ Super Bowl spot for compounded GLP-1 drugs draws Senate scrutiny
-
Barron’s: A Super Bowl Ad Sparks Controversy and Signals a New Era in U.S. Health
-
Pharmaceutical Technology: Super Bowl ad for copycat weight loss drugs stokes pharma power debate
It’s still going on. On the Tuesday after the game, ABC News ran “Super Bowl ad for Hims & Hers' weight loss drug sparks backlash” that included “experts” from TikTok complaining about the commercial, but with APC’s perspective adding a little, well, perspective.
